Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Cancers
|
January 10, 2026
Chemo-Radio-Immunotherapy Strategies to Prevent Immune Resistance in Non-Small Cell Lung Cancer
Renata-Andrea Rusu-Patraulea, Petronela Rusu, Tudor-Eliade Ciuleanu
Oncotargets and Therapy
|
December 1, 2021
Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer
Miruna Grecea, Olga Soritau, Daniel Dulf, et al.
Cancers
|
November 25, 2023
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
Raluca Munteanu, Ciprian Tomuleasa, Cristina-Adela Iuga, et al.
American Journal of Hematology
|
July 28, 2010
Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
Michael Auerbach, Peter T Silberstein, R Timothy Webb, et al.
Pathology Oncology Research : POR
|
January 6, 2015
Central and Eastern European experience with sunitinib in metastatic renal cell carcinoma: a sub-analysis of the global expanded-access trial
Eduard Vrdoljak, Lajos Géczi, Jozef Mardiak, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 26, 2018
Interobserver agreement in prostate cancer detection using multiparametric MRI
Cristian Popita, Anca-Raluca Popita, Adina Andrei, et al.
Medicina (Kaunas, Lithuania)
|
August 27, 2021
Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours
Liliana Maria Radulescu, Dan Radulescu, Tudor-Eliade Ciuleanu, et al.
Biomedicines
|
November 17, 2020
Cardiomyopathies and Arrhythmias Induced by Cancer Therapies
Dragoș-Mihai Romitan, Dan Rădulescu, Ioana Berindan-Neagoe, et al.
Investigational New Drugs
|
May 20, 2011
A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy
György Bodoky, Constanta Timcheva, David Robert Spigel, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 21, 2012
Novel cellular and molecular approaches to stratification and treatment of colorectal cancer
Nicolae Miron, Sergiu Susman, Ovidiu Balacescu, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Cancers
|
January 10, 2026
Chemo-Radio-Immunotherapy Strategies to Prevent Immune Resistance in Non-Small Cell Lung Cancer
Renata-Andrea Rusu-Patraulea, Petronela Rusu, Tudor-Eliade Ciuleanu
Oncotargets and Therapy
|
December 1, 2021
Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer
Miruna Grecea, Olga Soritau, Daniel Dulf, et al.
Cancers
|
November 25, 2023
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
Raluca Munteanu, Ciprian Tomuleasa, Cristina-Adela Iuga, et al.
American Journal of Hematology
|
July 28, 2010
Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
Michael Auerbach, Peter T Silberstein, R Timothy Webb, et al.
Pathology Oncology Research : POR
|
January 6, 2015
Central and Eastern European experience with sunitinib in metastatic renal cell carcinoma: a sub-analysis of the global expanded-access trial
Eduard Vrdoljak, Lajos Géczi, Jozef Mardiak, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 26, 2018
Interobserver agreement in prostate cancer detection using multiparametric MRI
Cristian Popita, Anca-Raluca Popita, Adina Andrei, et al.
Medicina (Kaunas, Lithuania)
|
August 27, 2021
Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours
Liliana Maria Radulescu, Dan Radulescu, Tudor-Eliade Ciuleanu, et al.
Biomedicines
|
November 17, 2020
Cardiomyopathies and Arrhythmias Induced by Cancer Therapies
Dragoș-Mihai Romitan, Dan Rădulescu, Ioana Berindan-Neagoe, et al.
Investigational New Drugs
|
May 20, 2011
A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy
György Bodoky, Constanta Timcheva, David Robert Spigel, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 21, 2012
Novel cellular and molecular approaches to stratification and treatment of colorectal cancer
Nicolae Miron, Sergiu Susman, Ovidiu Balacescu, et al.
Page
of 7